Pablo Lapuerta

2017

In 2017, Pablo Lapuerta earned a total compensation of $1.1M as Executive Vice President and Chief Medical Officer at Lexicon Pharmaceuticals, a 3% decrease compared to previous year.

Compensation breakdown

Bonus$100,233
Option Awards$424,303
Salary$394,604
Stock Awards$149,310
Other$11,609
Total$1,080,059

Lapuerta received $424.3K in option awards, accounting for 39% of the total pay in 2017.

Lapuerta also received $100.2K in bonus, $394.6K in salary, $149.3K in stock awards and $11.6K in other compensation.

Rankings

In 2017, Pablo Lapuerta's compensation ranked 8,620th out of 14,666 executives tracked by ExecPay. In other words, Lapuerta earned more than 41.2% of executives.

ClassificationRankingPercentile
All
8,620
out of 14,666
41st
Division
Manufacturing
3,272
out of 5,768
43rd
Major group
Chemicals And Allied Products
1,097
out of 2,074
47th
Industry group
Drugs
869
out of 1,730
50th
Industry
Pharmaceutical Preparations
680
out of 1,329
49th
Source: SEC filing on March 16, 2018.

Lapuerta's colleagues

We found four more compensation records of executives who worked with Pablo Lapuerta at Lexicon Pharmaceuticals in 2017.

2017

Lonnel Coats

Lexicon Pharmaceuticals

Chief Executive Officer

2017

Praveen Tyle

Lexicon Pharmaceuticals

Executive Vice President, Research and Development

2017

Jeffrey Wade

Lexicon Pharmaceuticals

Chief Financial Officer

2017

Alexander Santini

Lexicon Pharmaceuticals

Executive Vice President and Chief Commercial Officer

News

You may also like